You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
BBS as an Investment | Company Night Dec. 13, 2022
By Inderes
Ilkka Kangasniemi, CEO, talks about BBS as an investment.
Health Technology & Pharmaceutical Developer Night:
Keynote – Antti Siltanen, Inderes (link)
Faron – Markku Jalkanen, CEO (link)
Aiforia – Jukka Tapaninen, CEO (link)
Optomed – Seppo Kopsala, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
BBS – Ilkka Kangasniemi, CEO (link)
Bioretec – Timo Lehtonen, CEO (link)
Health Technology & Pharmaceutical Developer Night on inderesTV (link)